Global Information
회사소개 | 문의 | 비교리스트

세계의 스코폴라민 시장(2020-2026년)

Global Scopolamine Market 2020-2026

리서치사 Orion Market Research Pvt Ltd
발행일 2020년 06월 상품 코드 949522
페이지 정보 영문
가격
US $ 3,600 ₩ 4,023,000 Unprintable PDF (Single User License)
US $ 4,800 ₩ 5,364,000 Printable PDF (Enterprise License)


세계의 스코폴라민 시장(2020-2026년) Global Scopolamine Market 2020-2026
발행일 : 2020년 06월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 스코폴라민 시장은 예측 기간 중 4.5%의 CAGR로 확대할 것으로 예측됩니다. 이 약제는 멀미, 구역, 구토의 치료에 사용되고 있습니다. 또한 진정제로도 사용되며, 모르핀과 함께 사용하며 통증을 완화시킬 수 있습니다. 이 시장의 주요 성장요인으로는 스트레스 및 불안장애 환자 수의 증가를 들 수 있습니다. 또한 아시아태평양은 신흥 시장의 대폭적인 성장에 의해 예측 기간 중 순조롭게 성장할 것으로 예측되고 있습니다. 그러나 정부가 약물 유통에 관련된 규제를 강화할 가능성이 있으며, 약물의 불법사용 및 입수 가능한 대체약은 이 시장의 주요 과제입니다.

세계의 스코폴라민 시장에 대해 조사했으며, 시장 동향 및 기회, 성장 및 억제요인, 유형·투여 유형·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 리포트 개요

제2장 시장 개요와 인사이트

  • 조사 범위
  • 애널리스트의 인사이트와 현재의 시장 동향
  • 규칙과 규제

제3장 경쟁 구도

  • 기업 점유율 분석
  • 주요 전략 분석
  • 주요 기업 분석
    • Novartis AG
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Pfizer Inc.

제4장 시장 결정요인

  • 성장요인
  • 억제요인
  • 시장 기회

제5장 시장 세분화

  • 유형별
    • 스코폴라민 브롬화 부틸
    • 스코폴라민 기반
  • 투여 유형별
    • 경구
    • 패치
    • 주사

제6장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 프랑스
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타
  • 기타 지역

제7장 기업 개요

  • Alchem International Pvt. Ltd.
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Caleb Pharmaceuticals, Inc.
  • Fine Chemicals Corp.
  • Guangzhou Hanfang Pharmaceutical Co., Ltd.
  • Myungmoon Pharm Co. Ltd.
  • Novartis AG
  • Perrigo Co. plc
  • Pfizer Inc.
  • Phytex Australia
KSA 20.07.31

LIST OF TABLES

  • 1. GLOBAL SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL SCOPOLAMINE BUTYL BROMIDE MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 3. GLOBAL SCOPOLAMINE BASE MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 4. GLOBAL SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2019-2026 ($ MILLION)
  • 5. GLOBAL ORAL MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 6. GLOBAL PATCHES MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 7. GLOBAL INJECTIONS MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 8. NORTH AMERICAN SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 9. NORTH AMERICAN SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 10. NORTH AMERICAN SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2019-2026 ($ MILLION)
  • 11. EUROPEAN SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 12. EUROPEAN SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 13. EUROPEAN SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2019-2026 ($ MILLION)
  • 14. ASIA PACIFIC SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 15. ASIA PACIFIC SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 16. ASIA PACIFIC SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2019-2026 ($ MILLION)
  • 17. REST OF THE WORLD SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 18. REST OF THE WORLD SCOPOLAMINE MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SCOPOLAMINE MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL SCOPOLAMINE MARKET SHARE BY DOSAGE TYPE, 2019 VS 2026 (%)
  • 3. GLOBAL SCOPOLAMINE MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 4. US SCOPOLAMINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA SCOPOLAMINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK SCOPOLAMINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE SCOPOLAMINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY SCOPOLAMINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. ITALY SCOPOLAMINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. SPAIN SCOPOLAMINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. REST OF EUROPE SCOPOLAMINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. INDIA SCOPOLAMINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. CHINA SCOPOLAMINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. JAPAN SCOPOLAMINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC SCOPOLAMINE MARKET SIZE, 2019-2026 ($ MILLION)

Global Scopolamine Market Size, Share & Trends Analysis Report, By Type (Scopolamine Butyl bromide and Scopolamine Base), By Dosage Type (Oral, Patches, and Injections) and Forecast, 2020-2026

The scopolamine market is anticipated to augment at a CAGR of 4.5% during the forecast period. The drug is used to treat motion sickness & nausea and vomiting. Moreover, it is also used as a sedative and can be used along with the morphine to relieve pain. Key dynamics augmenting the market include a rise in the number of people suffering from stress and anxiety disorder.

However, misuse of the drug for illegal activities is one of the major challenges to market growth as the government may strict the regulations related to the distribution of the drug. Moreover, alternative drugs available in the market is a restraining factor for the drug. Ondansetron, Promethazine, Prochlorperazine are some of the alternative drugs available in the market for the treatment of nausea and vomiting.

The global scopolamine market is divided on the basis of type and dosage type. By type, the market is bifurcated into scopolamine butyl bromide and scopolamine base, whereas by dosage type, it is segmented into oral, injection, and patches. Scopolamine patches have been widely adopted to treat nausea and vomiting due to motion sickness or as anesthesia during surgery.

By geography, the global scopolamine market is further divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to hold a major market share during the forecast period. The high cost of drugs, frequent traveling of people through airways for small distances, well-developed online supply chains are some of the key factors for the major market share to the region. Moreover, Asia-Pacific is expected to show a lucrative growth rate during the forecast period due to the significant growth in the emerging markets.

Major players operating in the market include Novartis AG, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Baxter International Inc., Myungmoon Pharm Co. Ltd., Alchem International Pvt. Ltd., Caleb Pharmaceuticals, Inc., Phytex Australia, Fine Chemicals Corp., Perrigo Company plc and others. These companies are implementing various growth strategies which include mergers & acquisitions, product launches, and partnerships & collaborations to gain a competitive edge in the market.

Research Methodology

The market study of the global scopolamine market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to breakdown the market in the various segment, derive total market size, market forecast, and growth rates. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to amplify the added validity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Scopolamine Market Research and Analysis, By Type
  • Global Scopolamine Market Research and Analysis, By Dosage Type

The Report Covers:

  • Comprehensive research methodology of the Global Scopolamine Market.
  • A detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Scopolamine Market.
  • Insights about market determinants which are stimulating the Global Scopolamine Market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdowns
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Novartis AG
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Baxter International Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Boehringer Ingelheim International GmbH
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Pfizer Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Scopolamine Market by Type
    • 5.1.1. Scopolamine Butyl bromide
    • 5.1.2. Scopolamine Base
  • 5.2. Global Scopolamine Market by Dosage type
    • 5.2.1. Oral
    • 5.2.2. Patches
    • 5.2.3. Injections

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Alchem International Pvt. Ltd.
  • 7.2. Baxter International Inc.
  • 7.3. Boehringer Ingelheim International GmbH
  • 7.4. Cadila Healthcare Ltd.
  • 7.5. Caleb Pharmaceuticals, Inc.
  • 7.6. Fine Chemicals Corp.
  • 7.7. Guangzhou Hanfang Pharmaceutical Co., Ltd.
  • 7.8. Myungmoon Pharm Co. Ltd.
  • 7.9. Novartis AG
  • 7.10. Perrigo Co. plc
  • 7.11. Pfizer Inc.
  • 7.12. Phytex Australia
Back to Top
전화 문의
F A Q